canada clinical guidance

Insomnia

A Canadian clinical summary of insomnia, with source-attributed priorities and explicit jurisdiction boundaries.

JurisdictionCanada
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Canada
This is an iatroX educational summary of named Canada sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Ontario is used as an explicit Canadian implementation example, not as a national rule. Verify the equivalent pathway, formulary and escalation route in the patient鈥檚 province or territory.

Ontario source: bounded use

Management of Chronic Insomnia supplies a Canadian implementation example for this summary. It must not be presented as the rule outside Ontario.
sources for this section:CEP insomnia

Source-attributed clinical priorities

  • Identify chronicity, schedule, opportunity for sleep, daytime impairment, substances, medicines and coexisting sleep or mental disorders.
  • Use cognitive behavioural therapy for insomnia as foundational treatment for chronic insomnia.
  • If medication is used, define the indication, duration, monitoring and deprescribing plan, especially in older adults.
  • A two-week sleep diary often reveals schedule, variability and perpetuating behaviours more accurately than recall.
sources for this section:CEP insomnia

Practical assessment and management workflow

1
Confirm adequate sleep opportunity and record bedtime, wake time, latency, awakenings, naps and daytime effects.
2
Screen for sleep apnea, restless legs, circadian disorder, pain, mood, substances and medicine contributors.
3
Deliver stimulus control, sleep scheduling and cognitive strategies through CBT-I rather than sleep hygiene alone.
4
Review diary outcomes and taper short-term hypnotic treatment when behavioural change is established.
sources for this section:CEP insomnia

Safety, red flags and urgent escalation

  • Assess driving or workplace risk when daytime sleepiness is prominent.
  • Avoid combining hypnotics with alcohol, opioids or other sedatives.
  • New decreased need for sleep with elevated energy or behaviour suggests mania rather than primary insomnia.
sources for this section:CEP insomnia

Confirm the local pathway before acting

Ontario is used as an explicit Canadian implementation example, not as a national rule. Verify the equivalent pathway, formulary and escalation route in the patient鈥檚 province or territory.
sources for this section:CEP insomnia

Source and implementation boundary

Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:CEP insomnia

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Centre for Effective PracticeManagement of Chronic Insomniaaccessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Found a source update or regional discrepancy? Tell the iatroX editorial team.